Written by Klarity Editorial Team
Medically Reviewed by Dr. Sheelu Bhatnagar
Published: Feb 6, 2025

Key takeaway: Tirzepatide for weight loss follows a gradual titration schedule starting at 2.5 mg/week and increasing every 4 weeks to a maximum of 15 mg/week. Slow titration minimizes side effects and improves tolerability. Most patients reach their maintenance dose within 5–7 months.
Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →
Tirzepatide is the active ingredient in 2 brand-name medications — Mounjaro and Zepbound. If you’re taking either and hope to lose weight, using the right dose matters. Here, we give you a 101 on tirzepatide dosage for weight loss.
| Dose Level | Typical Timeline | Common Side Effects | Management Strategies |
|---|---|---|---|
| 2.5 mg/week | Weeks 1–4 (start) | Mild nausea, decreased appetite | Small meals; avoid high-fat foods; stay hydrated |
| 5 mg/week | Weeks 5–8 | Nausea, mild diarrhea or constipation | Small portions; time injection on lighter-meal days |
| 7.5 mg/week | Weeks 9–12 | Nausea, fatigue, possible vomiting | Ginger tea; rest after injection; avoid lying flat post-meal |
| 10 mg/week | Months 4–5 | GI symptoms, possible muscle aches | Electrolyte support; light exercise; provider check-in |
| 12.5 mg/week | Months 5–6 | GI symptoms, injection-site reactions | Rotate injection sites; maintain hydration |
| 15 mg/week (max) | Month 7+ | GI symptoms stabilize; hair thinning possible | Adequate protein intake; follow up with provider |
Mounjaro and Zepbound are the only available forms of FDA-approved tirzepatide. Tirzepatide is a combination GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) agonist. The dual action stimulates the pancreas to secrete insulin and slows gastric emptying, making you feel full and reducing appetite. In 2 different clinical trials, people taking tirzepatide lost 12.8 to 20.9% of their body weight in 72 weeks.
Mounjaro and Zepbound are available in the same 6 dosages: 2.5, 5, 7.5, 10, 12.5, and 15 milligrams per 0.5 milliliters, each in a prefilled single-dose pen. One dose is taken each week; a month’s supply requires 4 pens.
Zepbound and Mounjaro follow a stepped dosing schedule. You start at a low dose so your body can adjust, then increase every 4 weeks until reaching a maintenance dose. The target maintenance dose for Zepbound is typically 15 mg, where clinical studies show the greatest weight loss. Your provider may adjust the schedule if side effects arise — for example, increasing every 8 weeks rather than 4.
| Weeks | Zepbound dose | Mounjaro dose |
|---|---|---|
| Weeks 1–4 | 2.5 mg | 2.5 mg |
| Weeks 5–8 | 5 mg | 5 mg |
| Weeks 9–12 | 7.5 mg | 7.5 mg |
| Weeks 13–16 | 10 mg | 10 mg |
| Weeks 17–20 | 12.5 mg | 12.5 mg |
| Weeks 21+ | 15 mg (max) | 15 mg (max) |
The GLP-1 landscape has expanded significantly entering 2026, offering patients more options and broader access than ever before.
To get a prescription for tirzepatide, you need to speak with a licensed healthcare provider — such as an MD, nurse practitioner, or physician assistant. You can do that in-office or online through a healthcare marketplace, including Klarity Health. Your provider can determine if a weight loss medication is appropriate, obtain prior authorization if needed, and monitor your progress throughout your treatment.
Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) reduce appetite, slow digestion, and support blood sugar regulation. They are widely used for weight management and type 2 diabetes.
A licensed provider must evaluate your health history and BMI. Through Klarity, you can complete this entirely online with same-day appointments.
Many commercial plans may cover GLP-1 medications for obesity or metabolic conditions. Coverage varies by plan. Verify your benefits before booking.
Most GLP-1 side effects are dose-dependent and manageable through slow titration, dietary adjustments, and hydration. Your Klarity provider can personalize a management plan for you.
Klarity’s 2,000+ licensed providers can evaluate your eligibility, prescribe GLP-1 medications if appropriate, and help you manage side effects — all online. See if you may qualify →
Find the right provider for your needs — select your state to find expert care near you.